Palivizumab: References

Andabaka T, Nickerson JW, Rojas-Reyes, M, et al. Palivizumab for reducing the risk of severe RSV infection in children. Cochrane. http://summaries.cochrane.org/CD006602/palivizumab-for-reducing-the-risk-of-severe-rsv-infection-in-children. April 30, 2013. Accessed April 2016.

Brady MT, Byington CL, Davies HD, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics

August 2014, Volume 134, Issue 2. http://pediatrics.aappublications.org/content/134/2/415. Accessed April 2016.